William Blair’s biopharma investment banking team’s Quarterly Rx was cited by the The Wall Street Journal in its coverage of IPO activity and other investment trends in the sector.

Investment Banking
William Blair’s biopharma investment banking team’s Quarterly Rx was cited by the The Wall Street Journal in its coverage of IPO activity and other investment trends in the sector.
Stay up-to-date with the latest William Blair news and insights
William Blair’s acquisition of Inner Circle Sports (ICS) was discussed recently on Bloomberg TV’s “Open Interest” with Matt Zimmer, Global Head of Investment Banking, and Rob Tilliss, ICS co-founder and William Blair’s new Co-Head of Sports, Media & Entertainment.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures